Also, CRC patients with CEA ≥ 5 ng/ml had significantly greater levels of 5′-tRF-GlyGCC than that of patients with CEA < 5 ng/ml (Fig. 2e). This evidence concerns the gene CEACAM5 and colorectal carcinoma.